Return to: Medical School : Academic Health Center : myU : U of M Home

Gold University of Minnesota M. Skip to main content. Link to University of Minnesota homepage
Division of Hematology, Oncology, and Transplantation (HOT)
Whats Inside
Clinics

Contact Us

Education

Faculty

Fellow Bios

Links

Make a Gift

Minnesota Masons - A Legacy of Giving

Nurse Practitioners and Physician Assistants

Research Activities

Researchers

Schedules

Stem Cell Institute

Vascular Biology Center

Visitors

 

HOT Home

Masonic Clinic

Home > Faculty > Rudolph Keimowitz, M.D.

Printer-friendly version   Mail this page to a friend

Rudolph Keimowitz, M.D.


Dr. Keimowitz has joined the Fairview University Medical Center Palliative Care–Transitions and Life Choices (TLC) consult service and as liaison   to the Department of Hematology, Oncology and Transplantation as Clinical Associate Professor of Hematology.

Dr. Keimowitz received his BA (1958) and MD (1961) from the University of Vermont. He began his Internal Medicine residency training at the State University of New York in Syracuse and completed it at Boston City Hospital. He performed his fellowship training in Hematology at Boston City Hospital as well.

After service in the United States Army in Korea, he joined the Gundersen Clinic in LaCrosse, Wisconsin in 1967 as a Clinical Hematologist and practiced there until his retirement in December 2000. In addition to patient care, he was responsible for the interpretation of blood and bone marrow specimens and participated in the Internal Medicine residency teaching program. In 2001, he joined the Hematology Division at the Minneapolis Veterans Administration Hospital.

Dr. Keimowitz's clinical interest has been the diagnosis and treatment of benign and malignant hematologic disorders and, with that clinical perspective, now expands to palliative care. The major focus of his research has been the transdermal modification of platelet function utilizing his patented aspirin patch.

Selected Publications

Oken MM, Leong T, Lenhard RE Jr, Greipp PR, Kay NE, Van Ness B, Keimowitz RM, Kyle RA. The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma: Phase III Eastern Cooperative Oncology Group clinical trial EST 9486. Cancer 86:957-68, 1999.

Keimowitz RM.  Dementia improvement with cytotoxic chemotherapy: A case of Alzheimer disease and multiple myeloma.  Archives of Neurology 54:485-488, 1997.

McAdam B, Keimowitz RM, Maher M, Fitzgerald DJ.  Transdermal modification of platelet function: An aspirin patch system results in marked suppression of platelet cyclooxygenase.  The Journal of Pharmacology and Experimental Therapeutics 277:559-564, 1996.

Keimowitz RM, Pulvermacher G, Mayo G, Fitzgerald DJ.  Transdermal modification of platelet function, a dermal aspirin preparation selectively inhibits platelet cyclooxygenase and preserves prostacyclin biosynthesis.  Circulation 88:556-561, 1993.

Keimowitz RM, Collins J, Davis K, Aster RH. Post-transfusion purpura associated with alloimmunization against the platelet-specific antigen, Baka. American Journal of Hematology 21:79, 1986.

Keimowitz RM, Annis BL.  Disseminated intravascular coagulation associated with massive brain injury.  Journal of Neurosurgery 39:178-180, 1973.


Feedback | Notice of Privacy Practices


 
The University of Minnesota is an equal opportunity educator and employer.